Stay updated on GSK1349572 vs RAL in Integrase Inhibitor-Naive Adults Clinical Trial
Sign up to get notified when there's something new on the GSK1349572 vs RAL in Integrase Inhibitor-Naive Adults Clinical Trial page.

Latest updates to the GSK1349572 vs RAL in Integrase Inhibitor-Naive Adults Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange Detected- Added a prominent operating-status notice and updated version to v3.2.0. - Removed the old v3.1.0 tag.SummaryDifference1%

- Check33 days agoChange DetectedAdded a new publication entry and updated revision tag from v3.0.2 to v3.1.0; core content remains largely the same with a minor bibliographic update.SummaryDifference1%

- Check47 days agoChange DetectedVersion bump from v3.0.1 to v3.0.2 with removal of a 'Back to Top' element; no substantive changes to core content, pricing, stock, dates, or proper nouns.SummaryDifference0.1%

- Check54 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.1%

- Check62 days agoChange DetectedThe webpage has been updated to include new facility names and locations, as well as additional drug information related to HIV treatments. Notably, the total number of study locations has decreased from 181 to 180.SummaryDifference6%

- Check76 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.0%

Stay in the know with updates to GSK1349572 vs RAL in Integrase Inhibitor-Naive Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GSK1349572 vs RAL in Integrase Inhibitor-Naive Adults Clinical Trial page.